刚果民主共和国接受麻风腮疫苗情况

IF 7.2 2区医学 Q1 IMMUNOLOGY

Emerging Infectious Diseases Pub Date : 2024-10-23 DOI:10.3201/eid3012.241226

Skylar Petrichko, Jason Kindrachuk, Dalau Nkamba, Megan Halbrook, Sydney Merritt, Handdy Kalengi, Leonard Kamba, Michael Beya, Nicole A. Hoff, Christophe Luhata, Didine K. Kaba, Anne W. Rimoin

{"title":"刚果民主共和国接受麻风腮疫苗情况","authors":"Skylar Petrichko, Jason Kindrachuk, Dalau Nkamba, Megan Halbrook, Sydney Merritt, Handdy Kalengi, Leonard Kamba, Michael Beya, Nicole A. Hoff, Christophe Luhata, Didine K. Kaba, Anne W. Rimoin","doi":"10.3201/eid3012.241226","DOIUrl":null,"url":null,"abstract":"<p>We report general acceptance (61.0%) of an mpox vaccine in the Democratic Republic of the Congo among 5,226 survey respondents. Healthcare workers and respondents in historic mpox-endemic regions had higher acceptance rates. These data highlight the need for increased community engagement and sensitization before widespread deployment of mpox vaccines.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":7.2000,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mpox Vaccine Acceptance, Democratic Republic of the Congo\",\"authors\":\"Skylar Petrichko, Jason Kindrachuk, Dalau Nkamba, Megan Halbrook, Sydney Merritt, Handdy Kalengi, Leonard Kamba, Michael Beya, Nicole A. Hoff, Christophe Luhata, Didine K. Kaba, Anne W. Rimoin\",\"doi\":\"10.3201/eid3012.241226\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>We report general acceptance (61.0%) of an mpox vaccine in the Democratic Republic of the Congo among 5,226 survey respondents. Healthcare workers and respondents in historic mpox-endemic regions had higher acceptance rates. These data highlight the need for increased community engagement and sensitization before widespread deployment of mpox vaccines.</p>\",\"PeriodicalId\":11595,\"journal\":{\"name\":\"Emerging Infectious Diseases\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":7.2000,\"publicationDate\":\"2024-10-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Emerging Infectious Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3201/eid3012.241226\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emerging Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3201/eid3012.241226","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

我们报告了刚果民主共和国 5,226 名调查对象对天花疫苗的普遍接受度（61.0%）。医护人员和天花历史流行地区的受访者的接受率更高。这些数据凸显了在广泛使用天花疫苗之前加强社区参与和宣传的必要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Mpox Vaccine Acceptance, Democratic Republic of the Congo

We report general acceptance (61.0%) of an mpox vaccine in the Democratic Republic of the Congo among 5,226 survey respondents. Healthcare workers and respondents in historic mpox-endemic regions had higher acceptance rates. These data highlight the need for increased community engagement and sensitization before widespread deployment of mpox vaccines.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Emerging Infectious Diseases 医学-传染病学

CiteScore

17.30

自引率

1.70%

发文量

505

审稿时长

1 months

期刊介绍： Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination. Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.